References and Notes
For important recent reviews, see:
<A NAME="RU00907ST-1A">1a</A>
Krause N.
Hoffmann-Röder A.
Synthesis
2001,
171
<A NAME="RU00907ST-1B">1b</A>
Christoffers J.
Baro A.
Angew. Chem. Int. Ed.
2003,
42:
1688
For reviews, see:
<A NAME="RU00907ST-2A">2a</A>
Dalko PI.
Moisan L.
Angew. Chem. Int. Ed.
2004,
43:
5138
<A NAME="RU00907ST-2B">2b</A>
Berkessel A.
Gröger H.
Asymmetric Organocatalysis
Wiley-VCH;
Weinheim:
2004. and references cited therein
<A NAME="RU00907ST-3">3</A>
List B.
Pojarliev P.
Martin HJ.
Org. Lett.
2001,
3:
2423
<A NAME="RU00907ST-4">4</A>
Betancort JM.
Barbas CF.
Org. Lett.
2001,
3:
3737
<A NAME="RU00907ST-5">5</A>
Alexakis A.
Andrey O.
Org. Lett.
2002,
4:
3611
Thiourea-catalyzed asymmetric intermolecular Michael reactions:
<A NAME="RU00907ST-6A">6a</A>
Okino T.
Hoashi Y.
Takemoto Y.
J. Am. Chem. Soc.
2003,
125:
12672
<A NAME="RU00907ST-6B">6b</A>
Okino T.
Hoashi Y.
Furukawa T.
Xu XN.
Takemoto Y.
J. Am. Chem. Soc.
2005,
127:
119
<A NAME="RU00907ST-6C">6c</A>
Tsogoeva SB.
Yalalov DA.
Hateley MJ.
Weckbecker C.
Huthmacher K.
Eur. J. Org. Chem.
2005,
4995
For the leading reviews, see:
<A NAME="RU00907ST-7A">7a</A>
Connon SJ.
Chem. Eur. J.
2006,
12:
5418
<A NAME="RU00907ST-7B">7b</A>
Takemoto Y.
Org. Biomol. Chem.
2005,
3:
4299
<A NAME="RU00907ST-7C">7c</A>
Taylor MS.
Jacobsen EN.
Angew. Chem. Int. Ed.
2006,
45:
1520
Pioneering work of the intramolecular Michael reaction mediated by stoichiometric
amount of l-proline:
<A NAME="RU00907ST-8A">8a</A>
Kozikowski AP.
Mugrage BB.
J. Org. Chem.
1989,
54:
2274
<A NAME="RU00907ST-8B">8b</A> The use of chiral amine:
Hirai Y.
Terada T.
Yamazaki T.
Momose T.
J. Chem. Soc., Perkin Trans. 1
1992,
509
<A NAME="RU00907ST-9">9</A>
Fonseca MTH.
List B.
Angew. Chem. Int. Ed.
2004,
43:
3958
<A NAME="RU00907ST-10">10</A>
Hayashi Y.
Gotoh H.
Tamura T.
Yamaguchi H.
Masui R.
Shoji M.
J. Am. Chem. Soc.
2005,
127:
16028
<A NAME="RU00907ST-11">11</A>
Catalyst Preparation
To a solution of N-Boc-protected proline (50 g, 0.23 mol) in anhyd DMF (250 mL), Et3N (39 mL, 0.28 mol) was added and the mixture was cooled to 0 °C, then ethyl chloroformate
(22 mL, 0.23 mol) was added dropwise over 30 min. The reaction temperature was maintained
at 0 °C for 40 min, and then diisopropylaniline (44 mL, 0.23 mol) was added at 0 °C.
The reaction mixture was stirred at 65 °C for 14 h. The mixture was poured into H2O (150 mL) and crashed ice (150 mL). The precipitated solid was filtered and dried
in air. A part of the crude N-Boc-protected anilide (50 g) was dissolved in CHCl3 (100 mL) and TFA (98%, 100 mL) was added at r.t. The reaction mixture was stirred
at 50 °C for 2 h. The solvent was removed and the pH of the residue was adjusted to
8-9 by the addition of aq NaOH (2 N), the product was extracted with CHCl3, and dried over MgSO4. After removal of the solvent, the residue was purified by recrystallization from
hexane-TBME-CHCl3 (1:1:0.1; ca. 400 mL) to give 1d (30 g, 82%). The catalysts 1a-c were prepared in the same manner. Anilide 1a is also available from Fluorochem, Ltd. (order # 032341).
The spectral data for catalyst 1b: colorless needles; mp 79 °C; [α]D
26 -77.6 (c 1.00, CHCl3). 1H NMR (300 MHz, CDCl3): δ = 9.19 (br s, 1 H), 7.06 (m, 3 H), 3.92 (dd, J = 9.3, 5.1 Hz, 1 H), 3.14-2.99 (m, 2 H), 2.22 (s, 6 H), 2.14-2.03 (m, 1 H), 1.91-1.74
(m, 2 H). 13C NMR (75 MHz, CDCl3): δ = 172.9, 134.6, 133.7, 127.8, 126.4, 60.8, 47.5, 31.1, 26.4, 18.6. IR (KBr):
3281, 3003, 1669, 1501, 1098 cm-1. HRMS: m/z calcd for C13H18ON2 [M+]: 218.1419; found 218.1414.
Catalyst 1c: colorless needles; mp 78 °C; [α]D
25 -67.2 (c 1.00, CHCl3). 1H NMR (300 MHz, CDCl3): δ = 9.22 (br s, 1 H), 7.21-7.09 (m, 3 H), 3.91 (dd, J = 9.3, 5.1 Hz, 1 H), 3.13-2.97 (m, 2 H), 2.56 (q, J = 7.5 Hz, 4 H), 2.25-2.03 (m, 2 H), 1.90-1.75 (m, 2 H), 1.79 (t, J = 7.5 Hz, 6 H). 13C NMR (75 MHz, CDCl3): δ = 173.7, 140.8, 132.7, 127.2, 126.1, 65.0, 60.7, 47.5, 30.9, 26.4, 25.0, 14.5.
IR (KBr): 3280, 2969, 1668, 1500, 1298, 1240, 1100 cm-1. HRMS: m/z calcd for C15H22ON2 [M+]: 246.1732; found: 246.1741.
Catalyst 1d: colorless needles; mp 155 °C; [α]D
25 -58.7 (c 1.00, CHCl3). 1H NMR (300 MHz, CDCl3): δ = 9.14 (br s, 1 H), 7.29-7.15 (m, 3 H), 3.94 (dd, J = 9.3, 5.1 Hz, 1 H), 3.17-2.94 (m, 4 H), 2.30-2.05 (m, 2 H), 1.90-1.75 (m, 2 H),
1.22 (d, J = 3.9 Hz, 6 H), 1.20 (d, J = 3.9 Hz, 6 H); 13C NMR (75 MHz, CDCl3): δ = 174.2, 145.5, 131.4, 127.7, 123.2, 60.8, 47.6, 31.0, 28.9, 26.5, 23.7, 23.6.
IR (KBr): 3289, 2966, 1667, 1498, 1100 cm-1. Anal. Calcd for C17H26N2O: C, 74.41; H, 9.55; N, 10.21. Found: C, 74.30; H, 9.68; N, 10.10.
The use of both AcOH and H2O is critical. The cyclization of 2a without AcOH and H2O furnished lower reactivity in moderate enantioselectivity (catalyst 1a, 5 h, 92%, cis/trans = 44:56, 81% ee for cis, 62% ee for trans). The advantage of additives in aldol reaction, see:
<A NAME="RU00907ST-12A">12a</A>
Mase N.
Tanaka F.
Barbas CF.
Org. Lett.
2003,
5:
4369
<A NAME="RU00907ST-12B">12b</A>
Pihko PM.
Laurikainen KM.
Usano A.
Nyberg AI.
Kaavi JA.
Tetrahedron
2006,
62:
317
For the important correspondences about the water effect, see:
<A NAME="RU00907ST-12C">12c</A>
Brogan AP.
Dickerson TJ.
Janda KD.
Angew. Chem. Int. Ed.
2006,
45:
8100
<A NAME="RU00907ST-12D">12d</A>
Hayashi Y.
Angew. Chem. Int. Ed.
2006,
45:
8103 ; and references cited therein
<A NAME="RU00907ST-13">13</A>
General Procedure for Intramolecular Michael Reaction
To a mixture of anilide 1 (0.06 mmol, 30 mol%) and the corresponding formyl enone 2 (0.2 mmol) were added CHCl3 (2.5 mL), H2O (50 µL) and AcOH (0.06 mmol, 30 mol%) at 30 °C. The mixture was stirred at 30 °C
until TLC indicated complete reaction. The reaction was quenched at r.t. with H2O (1 mL) and extracted with Et2O (3 × 3 mL). The combined organic extracts were washed with brine, dried over Na2SO4, filtered and concentrated in vacuo. After purification by column chromatography
(silica gel, hexane-Et2O) furnished analytically pure 3a-c.
Compound cis-
3a: Chiral GC analysis (SUPELCO/β-DEX 325, 95 °C, 60 kPa H2 as carrier gas); t
R(minor) = 88.0 min, t
R(major) = 89.1 min. 1H NMR (300 Mz, CDCl3): δ = 9.70 (d, J = 2.4 Hz, 1 H), 2.99-2.91 (m, 1 H), 2.74-2.49 (m, 3 H), 2.13 (s, 3 H), 2.03-1.56
(m, 5 H), 1.35-1.25 (m, 1 H). 13C NMR (75 MHz, CDCl3): δ = 207.5, 204.6, 53.4, 44.7, 37.9, 32.1, 30.3, 25.5, 23.8.
Compound trans-3a: Chiral GC analysis (SUPELCO/β-DEX 325, 95 °C, 60 kPa H2 as carrier gas); t
R(major) = 94.2 min, t
R(minor) = 99.3 min. 1H NMR (300 Mz, CDCl3): δ = 9.59 (d, J = 3.2 Hz, 1 H) 2.60-2.50 (m, 3 H), 2.34-2.26 (m, 1 H), 2.12 (s, 3 H), 2.01-1.94 (m,
1 H), 1.85 (dd, J = 14.9, 7.6 Hz, 2 H), 1.77-1.57 (m, 2 H), 1.30-1.18 (m, 1 H). 13C NMR (75 MHz, CDCl3): δ = 207.4, 203.1, 57.6, 48.5, 36.2, 30.2, 26.8, 24.8.
Compound cis-3b: Chiral HPLC analysis; CHIRALPAK AD-H, hexane-i-PrOH (95:5), flow rate 1.0 mL/min, λ = 254 nm; t
R(minor) = 9.3 min, t
R(major) = 9.9 min. 1H NMR (300 Mz, CDCl3): δ = 9.77 (d, J = 2.4 Hz, 1 H), 7.96-7.92 (m, 2 H), 7.59-7.53 (m, 1 H), 7.48-7.43 (m, 2 H), 3.24
(dd, J = 17.1, 7.5 Hz, 1 H), 3.127-3.038 (m, 2 H), 2.88-2.75 (m, 1 H), 2.12 (s, 3 H), 2.08-1.61
(m, 5 H), 1.46-1.33 (m, 1 H). 13C NMR (75 MHz, CDCl3): δ = 204.4, 198.8, 136.6, 132.9, 128.4, 127.8, 53.6, 39.7, 38.4, 32.3, 25.7, 23.9.
Compound trans-3b: HPLC CHIRALPAK AS-H, hexane-i-PrOH (95:5), flow rate 0.5 mL/min, λ = 254 nm; t
R(minor) = 22.5 min, t
R(major) = 25.7 min. 1H NMR (300 Mz, CDCl3): δ = 9.66 (d, J = 3.3 Hz, 1 H), 7.94-7.91 (m, 2 H), 7.57-7.51 (m, 1 H), 7.47-7.41 (m, 2 H), 3.12
(dd, J = 17.1, 6.9 Hz, 1 H), 3.04 (dd, J = 17.1, 6.9 Hz, 1 H), 2.78-2.65 (m, 1 H), 2.40 (dt, J = 8.2, 3.3 Hz, 1 H), 2.11-2.00 (m, 1 H), 1.92-1.85 (m, 2 H), 1.83-1.62 (m, 2 H),
1.34 (ddd, J = 16.7, 12.5, 8.2 Hz, 1 H). 13C NMR (75 MHz, CDCl3): δ = 203.1, 198.7, 136.5, 132.9, 128.4, 127.8, 57.8, 43.6, 36.8, 33.1, 26.9, 24.9.
Compound cis-3c: Chiral GC analysis (SUPELCO/β-DEX 325, 105 °C, 80 kPa H2 as carrier gas); t
R(minor) = 96.2 min, t
R(major) = 97.8 min. 1H NMR (300 Mz, CDCl3): δ = 9.68 (d, J = 2.7 Hz, 1 H), 3.03-2.93 (m, 1 H), 2.71-2.57 (m, 3 H), 2.03-1.59 (m, 5 H), 1.34-1.20
(m, 2 H), 1.12 (s, 9 H). 13C NMR (75 MHz, CDCl3): δ = 214.6, 204.4, 53.4, 44.2, 38.1, 37.8, 32.3, 26.6, 25.7, 23.9.
Compound trans-3c: Chiral GC analysis (SUPELCO/β-DEX 325, 90 °C, 80 kPa H2 as carrier gas); t
R(major) = 243 min, t
R(minor) = 250 min. 1H NMR (300 Mz, CDCl3) δ = 9.57 (d, J = 3.6 Hz, 1 H), 2.71-2.49 (m, 3 H), 2.35-2.18 (m, 1 H), 2.06-1.92 (m, 2 H), 1.92-1.80
(m, 2 H), 1.78-1.56 (m, 1 H), 1.36-1.17 (m, 1 H), 1.11 (s, 9 H). 13C NMR (75 MHz, CDCl3): δ = 214.4, 203.1, 57.8, 44.0, 41.5, 36.5, 33.1, 26.9, 26.4, 24.9.
<A NAME="RU00907ST-14">14</A>
The same dr shift during the extended reaction time has been reported by Hayashi’s
group. They have succeeded in the isomerization from cis- to trans-isomer under the basic condition without loss of enantiopurity; see ref. 10.
<A NAME="RU00907ST-15">15</A>
It is assumed that this isomerization occurred through the diastereoselective protonation
or hydrolysis of enamine or iminium generated from further reaction between product
aldehyde 3 and catalyst. However, it cannot be seen that the isomerization occurred via the
same intermediate enamine or iminium in the cyclization reaction, because the dr in
the short reaction time is almost none selective (e.g. entry 1, Table
[3]
). Therefore we consider that this isomerization occurred via the enolate intermediate
forming from the aldehyde 3.
<A NAME="RU00907ST-16A">16a</A> The absolute stereochemistry of 3b was determined by comparison of its HPLC analysis reported by Hayashi et al., see
ref. 10 and:
Yang JW.
Fonseca MTH.
List B.
J. Am. Chem. Soc.
2005,
127:
15036
<A NAME="RU00907ST-16B">16b</A>
in the light of the reaction mechanism, we speculate that the other keto-aldehydes
3a and 3c have the same absolute configuration S at C2 (Figure
[2]
).